Down-regulation of renal endothelial nitric oxide synthase expression in experimental glomerular thrombotic microangiopathy

被引:15
|
作者
Zhou, XJ
Laszik, Z
Ni, ZM
Wang, XQ
Brackett, DJ
Lerner, MR
Silva, FG
Vaziri, ND
机构
[1] Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75235 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA
[3] Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Oklahoma City, OK USA
[4] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA
关键词
D O I
10.1038/labinvest.3780113
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Infection with certain strains of Escherichia coli and endotoxemia results in renal glomerular thrombotic microangiopathy (TMA) characterized by endothelial swelling and prominent glomerular microthrombus formation. Nitric oxide (NO) is an endogenous biologic modulator with diverse physiologic functions including vasodilation and inhibition of platelet adhesion and aggregation. NO is synthesized from conversion of L-arginine to L-citrulline by a family of NO synthases (NOS), which include constitutive and inducible isoforms. Indirect evidence supports the hypothesis that TMA is associated with depressed intrarenal NO production. However, the effect of TMA on renal tissue NOS expression has not been fully elucidated. We studied rats with TMA induced by iv bolus injection of high dose (20 mg/kg) E. coli endotoxin. Subgroups of six animals each were sacrificed before or at 30, 90, 180, 360, and 720 minutes after the administration of endotoxin. Renal histology and tissue expression of endothelial and inducible nitric oxide synthases (eNOS and iNOS) were examined. Additionally, we examined the effect of endotoxin on glomerular NO production, and eNOS and iNOS protein expression in vitro. Glomerular capillary thrombosis developed by 180 minutes after endotoxin administration in approximately half of the animals. The glomeruli without thrombotic lesions apparent by light microscopy disclosed early signs of TMA characterized by endothelial swelling, platelet accumulation/adhesion, and patchy fibrinogen deposition. These morphologic changes were associated with a marked reduction of renal tissue eNOS expression beyond 180 minutes after the endotoxin administration. The fall in eNOS expression was coupled with a significant rise in iNOS protein abundance, which was expressed largely by glomerular circulating neutrophils and endothelial cells, peritubular vascular endothelium, and collecting ducts of cortex and medulla. In vitro incubation of isolated glomeruli with endotoxin also resulted in a marked reduction in eNOS expression and a significant rise in iNOS content. Administration of E. coli endotoxin leads to a sustained fail in renal eNOS expression both in vivo and in vitro. The associated decline in intrarenal endothelial NO production/availability may result in renal vasoconstriction and a hypercoagulative state, which may contribute to the pathogenesis of endotoxin-induced TMA.
引用
收藏
页码:1079 / 1087
页数:9
相关论文
共 50 条
  • [1] Renal nitric oxide synthase (NOS) expression in experimental glomerular thrombotic microangiopathy (TMA).
    Zhou, XJ
    Laszik, Z
    Ni, Z
    Silva, FG
    Vaziri, ND
    LABORATORY INVESTIGATION, 1999, 79 (01) : 159A - 159A
  • [2] Down-regulation of endogenous nitric oxide synthase inhibitors on endothelial SK3 expression
    Zhou, Zhi
    Jiang, De-Jian
    Jia, Sti-He
    Xiao, Hong-Bo
    Xiao, Bo
    Li, Yuan-Jian
    VASCULAR PHARMACOLOGY, 2007, 47 (5-6) : 265 - 271
  • [3] Arsenite induces endothelial cytotoxicity by down-regulation of vascular endothelial nitric oxide synthase
    Tsou, TC
    Tsai, FY
    Hsieh, YW
    Li, LA
    Yeh, SC
    Chang, LW
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 208 (03) : 277 - 284
  • [4] Statins blunt thrombin-induced down-regulation of endothelial nitric oxide synthase expression in human endothelial cells
    Eto, Masato
    Rathgeb, Lisa
    Cosentino, Francesco
    Kozai, Toshiyuki
    Luescher, Thomas F.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 47 (05) : 663 - 667
  • [5] VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells
    Feliers, D
    Chen, XY
    Akis, N
    Choudhury, GG
    Madaio, M
    Kasinath, BS
    KIDNEY INTERNATIONAL, 2005, 68 (04) : 1648 - 1659
  • [6] Expression and regulation of endothelial nitric oxide synthase
    Sase, K
    Michel, T
    TRENDS IN CARDIOVASCULAR MEDICINE, 1997, 7 (01) : 28 - 37
  • [7] Antioxidants inhibit human endothelial cell functions through down-regulation of endothelial nitric oxide synthase activity
    Polytarchou, C
    Papadimitriou, E
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 510 (1-2) : 31 - 38
  • [8] Regulation of expression of the endothelial cell nitric oxide synthase
    Harrison, DG
    Sayegh, H
    Ohara, Y
    Inoue, N
    Venema, RC
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1996, 23 (03): : 251 - 255
  • [9] Gut mediated systemic down-regulation of nitric oxide synthase-2 expression.
    Bian, K
    Harari, Y
    Lai, M
    Weisbrodt, N
    Murad, F
    GASTROENTEROLOGY, 2000, 118 (04) : A813 - A813
  • [10] Antioxidants inhibit angiogenesis in vivo through down-regulation of nitric oxide synthase expression and activity
    Polytarchou, C
    Papadimitriou, E
    FREE RADICAL RESEARCH, 2004, 38 (05) : 501 - 508